Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2918
Source ID: NCT00331604
Associated Drug: Inhaled Human Insulin
Title: Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: inhaled human insulin|DRUG: insulin detemir|DRUG: insulin aspart|DRUG: insulin aspart
Outcome Measures: Primary: Treatment difference in HbA1c, After 52 weeks | Secondary: Adverse events, For the duration of the trial|Blood glucose, After 52, 104 and 116 weeks of treatment|Body weight, During treatment|Lung function, After 52, 104 and 116 weeks of treatment|Hypoglycaemia, From 12 weeks of treatment
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 618
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2006-08-31
Completion Date: 2008-05-05
Results First Posted:
Last Update Posted: 2017-03-01
Locations: Novo Nordisk Investigational Site, Campinas, 13083-900, Brazil|Novo Nordisk Investigational Site, Higienopolis, 01244-030, Brazil|Novo Nordisk Investigational Site, Porto Alegre, 90035-170, Brazil|Novo Nordisk Investigational Site, Sao Paulo, 04022-001, Brazil|Novo Nordisk Investigational Site, Hillerød, 3400, Denmark|Novo Nordisk Investigational Site, Hvidovre, 2650, Denmark|Novo Nordisk Investigational Site, Århus C, 8000, Denmark|Novo Nordisk Investigational Site, Brest, 29200, France|Novo Nordisk Investigational Site, GRENOBLE cedex, 38043, France|Novo Nordisk Investigational Site, LA ROCHELLE cedex, 17019, France|Novo Nordisk Investigational Site, Nanterre, 92014, France|Novo Nordisk Investigational Site, Narbonne, 11108, France|Novo Nordisk Investigational Site, NEVERS cedex, 58033, France|Novo Nordisk Investigational Site, Strasbourg, 67091, France|Novo Nordisk Investigational Site, TOULOUSE cedex, 31054, France|Novo Nordisk Investigational Site, Bad Harzburg, 38667, Germany|Novo Nordisk Investigational Site, Bad Kreuznach, 55545, Germany|Novo Nordisk Investigational Site, Bad Lauterberg, 37431, Germany|Novo Nordisk Investigational Site, Dresden, 01219, Germany|Novo Nordisk Investigational Site, Dresden, 01307, Germany|Novo Nordisk Investigational Site, Friedrichsthal, 66299, Germany|Novo Nordisk Investigational Site, Hamburg, 21073, Germany|Novo Nordisk Investigational Site, Hamburg, 22607, Germany|Novo Nordisk Investigational Site, Herrenberg, 71083, Germany|Novo Nordisk Investigational Site, Hohenmölsen, 06679, Germany|Novo Nordisk Investigational Site, Neumünster, 24534, Germany|Novo Nordisk Investigational Site, Neuwied, 56564, Germany|Novo Nordisk Investigational Site, Schkeuditz, 04435, Germany|Novo Nordisk Investigational Site, Speyer, 67346, Germany|Novo Nordisk Investigational Site, St. Ingbert, 66386, Germany|Novo Nordisk Investigational Site, Völklingen, 66333, Germany|Novo Nordisk Investigational Site, Warburg, 34414, Germany|Novo Nordisk Investigational Site, Shatin, New Territories, Hong Kong|Novo Nordisk Investigational Site, Beer Sheva, 84101, Israel|Novo Nordisk Investigational Site, Holon, 58100, Israel|Novo Nordisk Investigational Site, Jerusalem, 91120, Israel|Novo Nordisk Investigational Site, Bari, 70124, Italy|Novo Nordisk Investigational Site, Catania, 95122, Italy|Novo Nordisk Investigational Site, Catanzaro, 88100, Italy|Novo Nordisk Investigational Site, Milano, 20132, Italy|Novo Nordisk Investigational Site, Perugia, 06126, Italy|Novo Nordisk Investigational Site, Pescara, 65124, Italy|Novo Nordisk Investigational Site, Pisa, 56100, Italy|Novo Nordisk Investigational Site, Roma, 00133, Italy|Novo Nordisk Investigational Site, Roma, 00168, Italy|Novo Nordisk Investigational Site, San Giovanni Rotondo, 71013, Italy|Novo Nordisk Investigational Site, Verona, 37126, Italy|Novo Nordisk Investigational Site, Singapore, 119074, Singapore|Novo Nordisk Investigational Site, Singapore, 159964, Singapore|Novo Nordisk Investigational Site, Almería, 04001, Spain|Novo Nordisk Investigational Site, Cáceres, 10004, Spain|Novo Nordisk Investigational Site, Elche, 3203, Spain|Novo Nordisk Investigational Site, Granada, 18012, Spain|Novo Nordisk Investigational Site, Lugo, 27004, Spain|Novo Nordisk Investigational Site, Mostoles - Madrid -, 28935, Spain|Novo Nordisk Investigational Site, Sevilla, 41014, Spain|Novo Nordisk Investigational Site, Valladolid, 47011, Spain|Novo Nordisk Investigational Site, Xátiva, 46800, Spain|Novo Nordisk Investigational Site, Taichung City, 407, Taiwan|Novo Nordisk Investigational Site, Taipei, 100, Taiwan|Novo Nordisk Investigational Site, Taipei, 114, Taiwan|Novo Nordisk Investigational Site, Aberdeen, AB25 1LD, United Kingdom|Novo Nordisk Investigational Site, Ayr, KA6 6DX, United Kingdom|Novo Nordisk Investigational Site, Bristol, BS10 5NB, United Kingdom|Novo Nordisk Investigational Site, Cosham, PO6 3LY, United Kingdom|Novo Nordisk Investigational Site, Edgbaston, Birmingham, B15 2TH, United Kingdom|Novo Nordisk Investigational Site, Edinburgh, EH16 4SA, United Kingdom|Novo Nordisk Investigational Site, Livingstone, EH54 6PP, United Kingdom|Novo Nordisk Investigational Site, Nottingham, NG7 2UH, United Kingdom|Novo Nordisk Investigational Site, Plymouth, PL6 8BQ, United Kingdom|Novo Nordisk Investigational Site, Salford, M6 8HD, United Kingdom|Novo Nordisk Investigational Site, Sheffield, S5 7AU, United Kingdom|Novo Nordisk Investigational Site, Wirral, Merseyside, CH63 4JY, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00331604

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress